David A. Garner

David Garner

Title: Chief Executive Officer
Company: Molecular Health Technologies
Location: Delray Beach, Florida, United States

David A. Garner, Chief Executive Officer at Molecular Health Technologies, has been recognized by Marquis Who’s Who Top Executives for dedication, achievements, and leadership in the vitamin industry.

To achieve an undergraduate degree, Mr. Garner attended the George Washington School of Business and majored in business administration and marketing. He successfully graduated in 1979. He had a friend whose company was active on the Wall Street trading floor, and that friend asked Mr. Garner if he was interested in pursuing work in the trading business. Mr. Garner said he was and accepted a position shortly thereafter. He worked as a market trader from 1990 until 2001, when he sustained a back injury. The injury, unfortunately, prohibited him from trading on the stock floor indefinitely. However, because of that, Mr. Garner was inspired to start a recession-proof company, and so he did.

In 2001, Mr. Garner opened Molecular Health Technologies, LLC. He is the present managing member and chief executive officer, as he has been for the last 18 years. He decided to invest in the vitamin industry because, unlike investing in stocks, people will use vitamins for as long as they desire to stay healthy, regardless of the status of any potential recession. Though his company started as an ingredient supplier, it has since transitioned to selling proprietary ingredients and proprietary delivery systems to meet market needs. Mr. Garner is active in a number of organizations in his industry, such as the American Herbal Products Association, the International Food Technologies, and the United States Cannabis Committee Board. He gives back to the community through his volunteering within the Vitamin Angels. Mr. Garner believes in consistently pushing the envelope and making his products better, which is what he will continue to do for as long as he is working.

Contact Mr. Garner:

Leave a Reply